Cytochrome P450 inhibitor/inducer treatment patterns among patients in the United States with advanced ovarian cancer who were prescribed or were eligible for poly(adenosine diphosphate [ADP]-ribose) polymerase inhibitors in the first-line maintenance setting
美国晚期卵巢癌患者在接受一线维持治疗时，使用细胞色素P450抑制剂/诱导剂的治疗模式，这些患者要么被处方使用聚腺苷二磷酸[ADP]-核糖聚合酶抑制剂，要么符合使用此类抑制剂的条件。
期刊:Gynecologic Oncology Reports
影响因子:1.3
doi:10.1016/j.gore.2024.101332
Rimel, Bobbie J; Chase, Dana M; Perhanidis, Jessica; Ghazarian, Armen A; Du, Ella Xiaoyan; Wang, Travis; Song, Jinlin; Golembesky, Amanda K; Hurteau, Jean A; Kalilani, Linda; Salani, Ritu; Monk, Bradley J
